Literature DB >> 29948170

Sexual functioning after total versus subtotal laparoscopic hysterectomy.

Sebastian Berlit1, Benjamin Tuschy1, Anne Wuhrer1, Sven Jürgens2, Olaf Buchweitz2, Anna-Theresa Kircher1, Marc Sütterlin1, Stefanie Lis3, Amadeus Hornemann4.   

Abstract

AIM: To evaluate postoperative sexual functioning and the influence of patients' expectations on the change in sexuality following laparoscopic total (TLH) versus subtotal hysterectomy (LASH).
METHODS: A total of 120 women undergoing laparoscopic hysterectomy were preoperatively enrolled in this bicentric prospective study. Sexual functioning (SF) was evaluated using the female sexual function index (FSFI). Additionally, participants filled in a standardised questionnaire concerning expected changes in SF after surgery. At 3, 6 and 12 months following surgery, women were asked again to assess their level of SF (FSFI). Data of women who participated in at least one FSFI follow-up assessment were analysed (n = 92). We compared the change in SF after surgery between patients with TLH (n = 46) and LASH (n = 46). Additionally, we calculated regression analyses with the patients' expectations as a predictor for change in FSFI scores.
RESULTS: Comparing the change of FSFI scores after surgery in both collectives revealed differences only 3 months after surgery, as improvement was stronger for the LASH collective compared to the THL group (p = 0.006). There were no changes comparing collectives after 6 (p = 0.663) and 12 (p = 0.326) months. Concerning patients' expectations, for the LASH group baseline SF (p < 0.001), but not expectations (p = 0.567) predicted the strength of change at each of the follow ups: a lower level of baseline SF was linked to a stronger improvement after surgery. For the THL collective, both baseline SF (p < 0.001) as well as patients' expectations (3 months: p = 0.077, 6 months: p = 0.37, 12 months: p = 0.024) predicted the strength of change: both, a lower level of baseline SF and higher expectations towards an improvement predicted a stronger improvement.
CONCLUSION: The preservation of the cervix does not show an advantage in improving SF after surgery. Both methods induce a comparable improvement in long-time SF, especially in patients with an impaired sexuality pre-surgery. Furthermore, patients' expectations concerning this matter seem to have an impact on the postoperative outcome; therefore, this circumstance should be considered in future projects.

Entities:  

Keywords:  Cervix; Laparoscopic hysterectomy; Patient expectations; Sexuality; Supracervical hysterectomy

Mesh:

Year:  2018        PMID: 29948170     DOI: 10.1007/s00404-018-4812-7

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  4 in total

1.  The influence of conventional and extended supracervical hysterectomy on sexuality and quality of life parameters: a prospective bi-center study with a special focus on postoperative spotting.

Authors:  C Spüntrup; M Banerjee; M Bordelius; M Hellmich; J Bojahr; B Bojahr; C Albus; G Noé
Journal:  Arch Gynecol Obstet       Date:  2022-01-10       Impact factor: 2.344

Review 2.  Abnormal Uterine Bleeding in Perimenopausal Women: The Role of Hysteroscopy and Its Impact on Quality of Life and Sexuality.

Authors:  Salvatore Giovanni Vitale; Rafał Watrowski; Fabio Barra; Maurizio Nicola D'Alterio; Jose Carugno; Thozhukat Sathyapalan; Ilker Kahramanoglu; Enrique Reyes-Muñoz; Li-Te Lin; Bulent Urman; Simone Ferrero; Stefano Angioni
Journal:  Diagnostics (Basel)       Date:  2022-05-09

3.  Large pelvic mass arising from the cervical stump: A case report.

Authors:  Kai Zhang; Jing-Hong Jiang; Jia-Li Hu; Yu-Lin Liu; Xu-Hong Zhang; Ying-Mei Wang; Feng-Xia Xue
Journal:  World J Clin Cases       Date:  2020-01-06       Impact factor: 1.337

4.  Cervical stump necrosis after laparoscopic supracervical hysterectomy: successful management by laparoscopic approach.

Authors:  Xin Le; Nasuh Utku Dogan; Giovanni Favero; Christhardt Köhler
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.